Progressive Weight Loss and Metabolic Health



Status:Active, not recruiting
Conditions:Obesity Weight Loss, Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:21 - 65
Updated:4/21/2016
Start Date:February 2011
End Date:July 2016

Use our guide to learn which trials are right for you!

This study will evaluate the potential beneficial cardiometabolic effect of moderate (5%)
weight loss and progressive (5%, 10%, and 15%) weight loss in obese adults without diabetes.
Participants will be randomly assigned to one of 2 groups. Group 1: supervised weight loss
group (low-calorie diet). Group 2: supervised weight maintenance group (normal diet). Of
those assigned to group 1, half of the participants will lose 5% of their body weight and
the other half will lose 5%, 10%, and 15% of their weight over time under the guidance of a
dietitian. Research testing will be repeated at each time point (5%, 10%, and 15% weight
loss). In group 2, research testing will be repeated after six months.


Inclusion Criteria:

- Obese: Body Mass Index from 30 to 45

- Insulin Resistant: HOMA-IR score greater than or equal to 2

Exclusion Criteria:

- diabetes

- smoking

- pregnancy

- breastfeeding

- heart failure

- history of liver disease including hepatitis

- alcoholism

- exercise more than 2 hours per week
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials